EN FR
By kristalamb
Posted date: September 08, 2020
Diagram of Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes
A figure from the publication.

 

A paper from Diabetes Action Canada researchers Drs. Peter Senior, Bruce Perkins and Remi Rabasa-Lhoret, along with Patient Partner Kate Farnsworth, was recently released in the journal Springer Nature.

The paper, Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes, looks in detail at these treatment options.

Read the paper here.

 

 


Articles

Diabetes Action Canada September Webinar Series

Program provides relevant supports for older adults with diabetes

Diabetes Action Canada | SPOR Network
200 Elizabeth Street
Eaton Building, Room 12E242
Toronto, Ontario M5G 2C4 Canada

416-340-4800 ex. 2522
info@diabetesaction.ca